MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 781 to 800 of 166,322 approvalsPage 40 of 8317

Bendamustine Hydrochloride for Injection

Approval Number: 国药准字H20253886
Registration: Apr 15, 2025

Mirtazapine Tablets

Approval Number: 国药准字HJ20250044
Registration: Apr 15, 2025

Peramivir Injection

Approval Number: 国药准字H20253945
Registration: Apr 15, 2025

Ticagrelor Dispersible Tablets

Approval Number: 国药准字H20253893
Registration: Apr 15, 2025

Ravulizumab Injection

Approval Number: 国药准字SJ20250015
Registration: Apr 15, 2025

Carboplatin Injection

Approval Number: 国药准字H20253911
Registration: Apr 15, 2025

Dapagliflozin Tablets

Approval Number: 国药准字H20253906
Registration: Apr 15, 2025

Carboplatin Injection

Approval Number: 国药准字H20253912
Registration: Apr 15, 2025

Ephedrine Hydrochloride Injection

Approval Number: 国药准字H41022708
Registration: Apr 15, 2025

Amisulpride Oral Solution

Approval Number: 国药准字HJ20250043
Registration: Apr 15, 2025
syri limited

Tramadol Hydrochloride Capsules

Approval Number: 国药准字HJ20140362
Registration: Apr 15, 2025
medochemie ltd.

Diquafosol Sodium Eye Drops

Approval Number: 国药准字H20253919
Registration: Apr 15, 2025

Trifluridine and Tipiracil Hydrochloride Tablets

Approval Number: 国药准字H20253941
Registration: Apr 15, 2025

咳特灵胶囊

Approval Number: 国药准字Z41022183
Registration: Apr 15, 2025

Recombinant Human Follitropin Prefilled Syringe

Approval Number: 国药准字S20258004
Registration: Apr 15, 2025

Methocarbamol Injection

Approval Number: 国药准字H20253875
Registration: Apr 15, 2025

Lacosamide Tablets

Approval Number: 国药准字H20253870
Registration: Apr 15, 2025

Diquafosol Sodium Eye Drops

Approval Number: 国药准字H20253907
Registration: Apr 15, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.